CJC 1295 (without DAC)
Product Details
CJC-1295 Without DAC 5mg + Ipamorelin 5mg — Research Peptide Blend
CJC-1295 Without DAC + Ipamorelin is a research-use peptide blend containing two growth hormone secretagogue-related compounds commonly studied for their interaction with growth hormone signaling pathways. This combination is designed for laboratory research examining peptide receptor activity, growth hormone release mechanisms, pituitary signaling, and related endocrine research models.
CJC-1295 Without DAC, also known as Modified GRF 1-29, is a synthetic growth hormone-releasing hormone analog studied for its ability to stimulate pulsatile growth hormone release without the extended half-life associated with DAC-modified versions. Ipamorelin is a selective ghrelin/growth hormone secretagogue receptor agonist studied for its GH-releasing activity and selectivity profile. The National Cancer Institute describes ipamorelin as a ghrelin mimetic that binds the growth hormone secretagogue receptor and stimulates GH release from the pituitary.
Research on CJC-1295 has shown prolonged stimulation of growth hormone and IGF-1 secretion in clinical study settings, while additional research found that GH pulsatility was preserved during CJC-1295 exposure. Ipamorelin has also been studied as a selective growth hormone secretagogue, with early pharmacology research describing its potent GH-releasing activity and selectivity compared with other secretagogues.
This blend is supplied as a lyophilized powder for qualified laboratory research applications only.
Product Details
Product Name: CJC-1295 Without DAC + Ipamorelin
Amount: 5mg CJC-1295 Without DAC + 5mg Ipamorelin
Form: Lyophilized powder
Grade: Research use only
Application: Laboratory research and analytical testing only
Storage: Store in a cool, dry place. Follow proper laboratory storage protocols.
Research Areas
This compound blend may be used in research related to:
Growth hormone secretagogue receptor activity
Growth hormone-releasing hormone analog studies
Pituitary signaling pathway research
GH and IGF-1 pathway investigation
Peptide stability and receptor interaction studies
Endocrine signaling research models
Lorem ipsum dolor ist amte, consectetuer adipiscing eilt. Aenean commodo ligula egget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quak felis, ultricies nec, pellentesque eu, pretium quid, sem.
